Luca Visani - Concepedia

Author

Luca Visani

Azienda Ospedaliero-Universitaria Careggi ORCID

Also Known As

L Visani, L. Visani, Luca Visani, Visani, Luca

159

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Azienda Ospedaliero-Universitaria Careggi University of Florence Institut Curie Sheba Medical Center University of Genoa

About

Luca Visani is an author at Azienda Ospedaliero-Universitaria Careggi specializing in oncology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	471
2	Health Sciences	7	7	306
3	Neurology	1	1	28
4	Orthopaedics	1	1	19
5	Pathology	1	1	13

Luca Visani

Publications

642

Citations

H-Index

Page 1

	Year	Citations
Exclusive endocrine therapy or partial breast irradiation for women aged ≥70  years with luminal A-like early stage breast cancer (NCT04134598 – EUROPA): Proof of concept of a randomized controlled trial comparing health related quality of life by patient reported outcome measures Icro Meattini, Philip Poortmans, L. Marrazzo, Journal of Geriatric Oncology Health Related QualityQuality Of LifeBreast OncologyExclusive Endocrine TherapyMedicine	2020	79
International multidisciplinary consensus on the integration of radiotherapy with new systemic treatments for breast cancer: European Society for Radiotherapy and Oncology (ESTRO)-endorsed recommendations Icro Meattini, Carlotta Becherini, Saverio Caini, The Lancet Oncology Radiation MedicineBreast OncologyRadiation TherapyNew Systemic TreatmentsMedicine	2024	69
Cardioprotective Strategy for Patients With Nonmetastatic Breast Cancer Who Are Receiving an Anthracycline-Based Chemotherapy Lorenzo Livi, Giuseppe Barletta, Francesca Martella, JAMA Oncology	2021	65
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial Icro Meattini, Maria Carmen De Santis, Luca Visani, The Lancet Oncology Endocrine OncologySurgical OncologyBreast OncologyMedicinePreplanned Interim Analysis	2024	53
Pregnancy After Breast Cancer in Young <i>BRCA </i>Carriers Matteo Lambertini, Eva Blondeaux, Elisa Agostinetto, JAMA	2023	49
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? Pierluigi Bonomo, Daniela Greto, Isacco Desideri, Oral Oncology Clinical OutcomeRadiation TherapyMedicineRadionuclide TherapyLung-only Oligometastatic Head	2019	48
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group Paolo Borghetti, Marco Lorenzo Bonù, Rachele Giubbolini, La radiologia medica Radiation MedicineRadiation TherapyMulticentric AnalysisMedicineBronchial Neoplasm	2019	46
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer Isacco Desideri, Giulio Francolini, Vieri Scotti, Clinical & Translational Oncology Health SciencesRadiation TherapyMedicineAblative VersusCancer Treatment	2018	30
Preoperative robotic radiosurgery for early breast cancer: Results of the phase II ROCK trial (NCT03520894) Icro Meattini, Giulio Francolini, Vanessa Di Cataldo, Clinical and Translational Radiation Oncology	2022	29
Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma Francesco Pasqualetti, Nicola Montemurro, Isacco Desideri, Acta Neurologica Belgica Neuro-oncologySurgical OncologyMedicineCancer RecurrenceSurgery	2021	28

Page 1